Cold chain packaging was built for a stable world. As disruption becomes the norm, pharma logistics teams are rethinking what control actually means and when it has to happen.

Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

Rahul Shah and Mack MacKenzie explain how to unlock the ROI that rules-based systems have left on the table.

RxLogic's Ann Beal on how PBM reform indirectly impacts pharma manufacturers' affordability programs, rebate planning, and patient access.

Erez Israeli explains how Dr. Reddy's approached commercial readiness for its generic semaglutide launch in Canada and what vertical integration in peptide manufacturing means for the GLP-1 market.

ORBIS' Matt Marchetti outlines how pharma companies can define supply chain impact, KPIs, and ROI when transitioning to reusable plastic pallets. By prioritizing solutions such as reusable plastic ...

Seamus Keane discusses resilient supply chain design ahead of his panel at LogiPharma 2026.

Ben Sharples, LogiPharma event director, examines how life sciences organizations are adapting to AI in the supply chain, with expert testimony from LogiPharma partners.

Wilhelm's comments describe a supply chain strategy built around flexibility, balancing inventory positioned close to ...

Geopolitical supply chain mapping identifies hidden dependencies across corridors, ports, airports, customs gateways, and carriers that can undermine continuity despite apparent supplier ...